| abstract |
The present invention relates to the use of at least one polysaccharide of fungal origin comprising predominantly a chitin-glucan copolymer, for the manufacture of an orally administered composition. In particular the present invention provides a pharmaceutical composition or dietary supplements to prevent, treat or fight especially dyslipidemia, hypercholesterolemia, atherosclerosis, and stimulate antioxidant activities of the body, stimulate the immune system, exercise a favorable hypoglycemic action in cases of diabetes, and promote satiety to to minimize the metabolic syndrome. |